Insider Transactions in Q2 2024 at Gossamer Bio, Inc. (GOSS)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2024
|
Richard Aranda Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,908
-0.96%
|
$0
$0.66 P/Share
|
|
Jun 21
2024
|
Faheem Hasnain President & CEO |
BUY
Open market or private purchase
|
Indirect |
372,000
+6.44%
|
$0
$0.67 P/Share
|
|
Jun 18
2024
|
Bryan Giraudo COO/CFO |
BUY
Open market or private purchase
|
Indirect |
100,000
+17.24%
|
$0
$0.59 P/Share
|
|
Jun 17
2024
|
Robert Paul Smith Jr Chief Commercial Officer |
BUY
Open market or private purchase
|
Indirect |
25,000
+50.0%
|
$0
$0.6 P/Share
|